19:16:46 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-14 Kvartalsrapport 2024-Q1
2024-04-29 Ordinarie utdelning OMDA 0.48 NOK
2024-04-25 Årsstämma 2024
2024-03-01 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-09-26 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-04-28 Ordinarie utdelning OMDA 0.00 NOK
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-30 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning OMDA 0.00 NOK
2022-05-19 Kvartalsrapport 2022-Q1
2022-05-19 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-07 Ordinarie utdelning OMDA 0.00 NOK
2021-05-06 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-11 Extra Bolagsstämma 2020
2020-11-27 Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2024-04-12 12:00:00
Oslo, Norway, 12 April 2024: The Board of Directors (the "Board") hereby calls
for an annual general meeting of Omda AS (the "Company") at the Company's
offices in Drammensveien 288, 0283 Oslo, at 13:00 CEST on 25 April 2024.

The agenda includes the approval of the 2023 Annual Report and accounts, the
Board of Directors' proposal for the distribution of dividends, the election of
board members, and the selection of members to the Nomination and Remuneration
Committee. Additionally, it involves the proposed granting of power of attorney
to the Board of Directors to acquire the Company's own shares and the approval
of remuneration for the Company's auditor, Board of Directors, and members of
the Nomination and Remuneration Committee.

The Board encourages all shareholders to submit proxy forms prior to the meeting
as an alternative to attending the meeting in person. You can cast your vote by
using the Proxy form with advance vote notice that is included in the attached
Notice to Annual General Meeting.

The documents will be distributed to all registered shareholders and are
available on omda.com.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 500 customers in 27
countries and employs almost 300 dedicated specialists. Our highly specialised
healthcare solutions empower medical professionals and emergency responders,
enabling them to know more and work smarter. With a focus on user-centric
design, value-driven development and close working relationships with customers,
Omda delivers solutions that enhance patient safety and improve healthcare
outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH